当前位置:首页 - 行情中心 - 九强生物(300406) - 财务分析 - 现金流量表

九强生物

(300406)

  

流通市值:57.93亿  总市值:80.03亿
流通股本:4.24亿   总股本:5.86亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,198,144,986.79789,809,846.24361,407,329.321,833,874,875.52
  收到的税费返还172,513.55172,513.55-115,487
  收到其他与经营活动有关的现金10,755,497.188,374,369.165,000,228.657,608,029.69
  经营活动现金流入小计1,209,072,997.52798,356,728.95366,407,557.921,891,598,392.21
  购买商品、接受劳务支付的现金226,254,284.44156,484,443.0875,496,196.47474,183,205.78
  支付给职工以及为职工支付的现金256,568,356.54195,158,215.5136,531,353.97320,253,024.06
  支付的各项税费152,406,070.55106,822,151.9443,495,060.14197,301,471.29
  支付其他与经营活动有关的现金147,010,714.895,815,267.7139,938,232.83285,848,761.82
  经营活动现金流出小计782,239,426.33554,280,078.23295,460,843.411,277,586,462.95
  经营活动产生的现金流量净额426,833,571.19244,076,650.7270,946,714.51614,011,929.26
二、投资活动产生的现金流量:
  收回投资收到的现金20,000,00019,760,00079,870,000550,000,000
  取得投资收益收到的现金279,736.12245,541.718,646,222.2421,290,140.84
  处置固定资产、无形资产和其他长期资产收回的现金净额153,529147,54486,744209,400
  处置子公司及其他营业单位收到的现金净额-0--
  收到的其他与投资活动有关的现金23,291,611.1523,000,000-100,808,012.58
  投资活动现金流入小计43,724,876.2743,153,085.7188,602,966.24672,307,553.42
  购建固定资产、无形资产和其他长期资产支付的现金30,312,420.4823,083,794.8117,138,675.4167,649,528.16
  投资支付的现金263,000,000213,000,000120,000,000623,277,680.53
  取得子公司及其他营业单位支付的现金-0--
  支付其他与投资活动有关的现金-0--
  投资活动现金流出小计293,312,420.48236,083,794.81137,138,675.41690,927,208.69
  投资活动产生的现金流量净额-249,587,544.21-192,930,709.1-48,535,709.17-18,619,655.27
三、筹资活动产生的现金流量:
  吸收投资收到的现金281,271.5283,373.47-571,288.98
  其中:子公司吸收少数股东投资收到的现金281,271.5283,373.47-571,288.98
  取得借款收到的现金998,487.31826,578.63470,716.2823,195,853.73
  收到其他与筹资活动有关的现金4,888,660.633,323,979.47284,149.335,491,723.56
  筹资活动现金流入小计6,168,419.444,433,931.57754,865.6129,258,866.27
  偿还债务支付的现金127,170,792.217,413,500.73537,445.5431,713,211.06
  分配股利、利润或偿付利息支付的现金423,454,639.34248,495,056.883,200,279.27127,600,348.58
  其中:子公司支付给少数股东的股利、利润3,011,0643,011,0643,011,0643,408,288
  支付其他与筹资活动有关的现金19,863,374.9919,320,466.09265,081.646,425,637.93
  筹资活动现金流出小计570,488,806.53285,229,023.74,002,806.41205,739,197.57
  筹资活动产生的现金流量净额-564,320,387.09-280,795,092.13-3,247,940.8-176,480,331.3
四、汇率变动对现金及现金等价物的影响-164,996.95-72,861.86-31,821.43515,978.68
五、现金及现金等价物净增加额-387,239,357.06-229,722,012.3719,131,243.11419,427,921.37
  加:期初现金及现金等价物余额1,131,058,401.841,131,058,401.841,042,657,721.31711,630,480.47
  期末现金及现金等价物余额743,819,044.78901,336,389.471,061,788,964.421,131,058,401.84
补充资料:
  净利润-175,713,965.16-531,162,206
  资产减值准备-11,802,212.65-5,815,456.3
  固定资产和投资性房地产折旧-30,099,664.85-60,604,000.28
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-30,099,664.85-60,604,000.28
  无形资产摊销-4,861,245.86-8,820,650.83
  长期待摊费用摊销-237,499.45-1,171,166.6
  处置固定资产、无形资产和其他长期资产的损失-749,603.05-2,112,317.8
  固定资产报废损失-598,201.16-1,379,740.26
  财务费用-23,783,087.71-47,089,406.34
  投资损失-742,471.47--9,613,993.45
  递延所得税--2,765,621.75--3,829,899
  其中:递延所得税资产减少--2,096,873.72--2,515,819.47
    递延所得税负债增加--668,748.03--1,314,079.53
  存货的减少-664,846.3--16,200,211
  经营性应收项目的减少-41,371,147.07-15,806,628.59
  经营性应付项目的增加--44,542,020.32--31,876,279.4
  一年内到期的可转换公司债券---5,605,119.49
  现金的期末余额-878,336,389.47-1,042,657,721.31
  减:现金的期初余额-1,042,657,721.31-711,630,480.47
  加:现金等价物的期末余额-23,000,000-88,400,680.53
  减:现金等价物的期初余额-88,400,680.53--
  现金及现金等价物的净增加额--229,722,012.37-419,427,921.37
公告日期2025-10-292025-08-272025-04-262025-03-29
审计意见(境内)标准无保留意见
TOP↑